BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9160424)

  • 1. Pharmacokinetics of tilmicosin in serum and milk of goats.
    Ramadan A
    Res Vet Sci; 1997; 62(1):48-50. PubMed ID: 9160424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tilmicosin antibacterial activity and pharmacokinetics in cows.
    Ziv G; Shem-Tov M; Glickman A; Winkler M; Saran A
    J Vet Pharmacol Ther; 1995 Oct; 18(5):340-5. PubMed ID: 8587151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Milk and blood pharmacokinetics of tylosin and tilmicosin following parenteral administrations to cows.
    Avci T; Elmas M
    ScientificWorldJournal; 2014; 2014():869096. PubMed ID: 25177733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of tilmicosin in lactating ewes.
    Atef M; Abo el-Sooud K; Nahed E; Tawfik M
    Dtsch Tierarztl Wochenschr; 1999 Jul; 106(7):291-4. PubMed ID: 10481373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of tilmicosin after oral administration in swine.
    Shen J; Li C; Jiang H; Zhang S; Guo P; Ding S; Li X
    Am J Vet Res; 2005 Jun; 66(6):1071-4. PubMed ID: 16008233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic profile of cefotaxime in goats.
    Atef M; Ramadan A; Afifi NA; Youssef SA
    Res Vet Sci; 1990 Jul; 49(1):34-8. PubMed ID: 2382053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of albendazole administration on pharmacokinetic aspects of tylosin in lactating goats.
    Atef M; Ramadan A; Darwish AS; Fahim AM
    Drug Metab Lett; 2009 Aug; 3(3):137-43. PubMed ID: 19702546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of tylosin in goats.
    Atef M; Youssef SA; Atta AH; el-Maaz AA
    Dtsch Tierarztl Wochenschr; 1991 Dec; 98(12):451-3. PubMed ID: 1790764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of tilmicosin in sheep and cattle.
    Modric S; Webb AI; Derendorf H
    J Vet Pharmacol Ther; 1998 Dec; 21(6):444-52. PubMed ID: 9885967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of theophylline on serum and milk pharmacokinetics of tylosin following intramuscular administration in lactating goats.
    El-Tareef FS; Abo-El-Sooud K; Karmi M; Hafez A
    BMC Vet Res; 2024 Jun; 20(1):251. PubMed ID: 38849822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of tilmicosin in equine tissues and plasma.
    Clark C; Dowling PM; Ross S; Woodbury M; Boison JO
    J Vet Pharmacol Ther; 2008 Feb; 31(1):66-70. PubMed ID: 18177321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of tylosin in goats.
    Atef M; Youssef SA; Atta AH; el-Maaz AA
    Br Vet J; 1991; 147(3):207-15. PubMed ID: 1878767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of plasma and lung concentrations after ceftiofur sodium and tilmicosin phosphate administered subcutaneously to mice.
    Brown SA; Deleeuw NR; Stahl GL; Roof RD
    J Vet Pharmacol Ther; 1995 Oct; 18(5):385-7. PubMed ID: 8587160
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness and kinetic behaviour of tilmicosin in the treatment of respiratory infections in sheep.
    Naccari F; Giofrè F; Pellegrino M; Calò M; Licata P; Carli S
    Vet Rec; 2001 Jun; 148(25):773-6. PubMed ID: 11465263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of tilmicosin in beef cattle following intravenous and subcutaneous administration.
    Lombardi KR; Portillo T; Hassfurther R; Hunter RP
    J Vet Pharmacol Ther; 2011 Dec; 34(6):583-7. PubMed ID: 21323676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogenated castor oil nanoparticles as carriers for the subcutaneous administration of tilmicosin: in vitro and in vivo studies.
    Han C; Qi CM; Zhao BK; Cao J; Xie SY; Wang SL; Zhou WZ
    J Vet Pharmacol Ther; 2009 Apr; 32(2):116-23. PubMed ID: 19290940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats.
    Fernández-Varón E; Villamayor L; Escudero E; Espuny A; Cárceles CM
    Vet J; 2006 Sep; 172(2):302-7. PubMed ID: 15908243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic profile of cefotaxime in goats.
    Atef M; Ramadan A; Afifi NA; Youssef SA
    Dtsch Tierarztl Wochenschr; 1990 Aug; 97(8):324-7. PubMed ID: 2209455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination kinetics of tilmicosin following intramammary administration in lactating dairy cattle.
    Smith GW; Davis JL; Baynes RE; Yeatts JL; Barlow BM; Riviere JE
    J Am Vet Med Assoc; 2009 Jan; 234(2):245-8. PubMed ID: 19210246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of administering long-acting oxytetracycline and tilmicosin either by dart gun or by hand on injection site lesions and drug residues in beef cattle.
    Van Donkersgoed J; VanderKop M; Salisbury C; Sears L; Holowath J
    Can Vet J; 1999 Aug; 40(8):583-7. PubMed ID: 12001341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.